Latest thinking.

Explore our latest insights and perspectives in these life science resources, news articles, and events.

Scroll

Topic

Content Type

Sunny side up – Biotech funding – 2025 & Beyond

Putnam shares key questions to consider in preparation of advancing trials and deals that have been put on hold.

Medicare price negotiation: Putnam’s round two picks

Putnam predicts the 15 drugs likely to be selected for the second round of Medicare Price Negotiations.

Emerging trends in complement therapeutics

Putnam has a proven track record of delivering superior strategic support to pharma leaders in developing strategies...

Incorporating the preferences of patients with rare ...

Health technology assessments (HTAs) are a crucial part of the journey to bring newly developed pharmaceuticals and medical devices to patients.

Leveraging indirect treatment comparisons in joint c...

In the evolving healthcare landscape, securing market access for new treatments often depends on how effectively their efficacy and safety...

Reflections of an Evolving Medical Affairs Skillset:...

MASS West 2024 showcased key themes in health equity, AI, and Real-World Evidence, helping Medical Affairs leaders tackle evolving challenges.

Revealing full value: Capturing equity impacts in ec...

As I take a moment to reflect on the past two-plus years of our AI journey and consider the predictions I made for 2024, it’s clear that many...

Putnam’s Demand Calibration Tool to increase demand ...

Putnam's Demand Calibration Tool enhances demand estimation accuracy by leveraging insights from 200+ studies across 50+ diseases and markets

Navigating the Joint Clinical Assessment (JCA) with ...

Navigate the JCA launch with Putnam's expert strategies. Unlock optimal market access with PICO-driven insights, evidence plans & regulatory synergy.

CEO Perspective: Three key observations two years in...

As I take a moment to reflect on the past two-plus years of our AI journey and consider the predictions I made for 2024, it’s clear that many...

Using AssetNav to Navigate Therapeutic Landscapes wi...

We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.

Recent Trends in Rare Diseases

Putnam experts share observations on recent global trends in the rare disease space and recommend strategies to maximize opportunities.

Load 12 more of 125

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Get in touch

Centers of Excellence

AI at Putnam

Open roles